Hermes-Epitek eyes CPO test revenue in 2027

CPO testing is shifting from availability to standard-setting power. The 2027 revenue anchor precisely targets the volume-ramp window for TSMC's CoWoS-L and Intel's Foveros Direct CPO production. Once optical engines are embedded in package substrates, serial test paradigms collapse—wafer-level opto-electro-thermal co-testing becomes mandatory, elevating test equipment vendors from end-of-line inspectors to yield-critical variables. On supply chain risk, fewer than five global suppliers can deliver high-precision optical alignment and sub-picosecond timing calibration. If BIS tightens export controls on optoelectronic test instruments, foundries in Taiwan, China and mainland China face acute equipment disruption, with domestic alternatives lagging 18-24 months minimum. Competitively, Keysight and Advantest are embedding CPO modules into ATE platforms to lock in customers, squeezing independent solution providers. Hermes-Epitek's moat lies in SiPh-level optical design IP that legacy ATE giants lack. However, Broadcom and Marvell will likely ship proprietary CPO test IP by H2 2026, compressing third-party pricing power. The 12-24 month inflection: OIF test standardization pace determines whether equipment vendors operate in custom or volume mode; once AI clusters exceed 100K GPUs, CPO shifts from optional to mandatory, driving exponential test demand. Whoever locks in hyperscaler test specifications first captures post-2027 pricing authority.